Heart Disease Trial, Recruiting NCT06692751 Sponsor: Centre Hospitalier Universitaire Dijon Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06692751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are being treated at Dijon University Hospital and have had a specific heart blood flow measurement (called IMR) taken during a coronary artery examination, as part of investigating chest pain or related symptoms without a clear blocked artery cause (a condition referred to as INOCA)
  • People whose coronary artery examination did not find a significant blockage or narrowing in the main heart arteries that would explain their symptoms
  • People who have given their oral (spoken) agreement to take part
  • Adults aged 18 or over

Who may not be able to join:

  • People who are not covered by the French social security system
  • People who are under a legal protection order, such as guardianship or curatorship, or who are subject to a court protection measure
  • Women who are pregnant or currently breastfeeding
  • Adults who are not able to understand or give their consent to participate
  • People who have a condition affecting the macula or retina of the eye, or who have severe short-sightedness in both eyes
  • People who have a genetic or unexplained heart muscle disease, such as dilated, hypertrophic, or restrictive cardiomyopathy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0380293031

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire Dijon
Registry
ClinicalTrials.gov
Start date
13 November 2024
Est. completion
1 November 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Retinal vascular density by "inner vessel length density" determined by OCT-A

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov